The trademark application ALBRIOZA was filed by Amylyx Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 10, 2022, and it was registered by office on October 17, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).